Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.
暂无分享,去创建一个
W. Scheithauer | H. Ludwig | A. Cortelezzi | G. Fillet | B. Van Camp | M. Peetermans | E. Polli | R. Kuzmits | R. Flener